On Thursday, May 3, 2018, Angie, our Team Captain, was diagnosed with breast cancer - Stage 2a invasive ductal carcinoma in her right breast. Angie is under 40. She caught it through a self-exam. We later learned that she also had a layer of DCIS (ductal carcinoma in situ) surrounding the invasive tumor. Angie is currently in treatment at Seattle Cancer Care Alliance ("SCCA"), which is a joint venture between UW Medicine and Fred Hutch.
At SCCA, Angie has already undergone a bilateral mastectomy and she had her first breast reconstruction surgery. At least one more surgery remains.
Chemotherapy starts July 21 and will last for 12 weeks, once a week. Thereafter, Angie has another 9 months of immunotherapy infusions. This immunotherapy is a miracle drug and it is going to save Angie's life. It was only found/developed through research at places like Fred Hutch. Angie participated in a clinical trial at SCCA pre-surgery where she received just one dose of this immunotherapy. It shrunk her tumor by several millimeters, so that the size change downgraded her cancer staging to Stage 1a after analyzing the new smaller sized tumor.
WE ARE COMMITTED TO CURING CANCER FASTER.
We are committing to Obliteride this August because we believe research is the fastest path to curing cancer, and we also believe the team at Fred Hutch can get us there.
Fred Hutch is part of the team which is saving Angie's life RIGHT NOW. Let's keep supporting Fred Hutch and its miracle work.
Why donate? Cancer will touch your life, or a family member's life. Sadly, half of all men and one third of all women in the U.S. will get cancer in their lifetime.
Fred Hutch is learning more about cancer prevention, diagnostics and treatment and Obliteride can help us get to cures faster.
More than 300 labs and projects are working hard to save the lives of people all over the world by conducting innovative, high-impact cancer research.
Please join us in this effort to put cancer in its place, behind us.
Ride or walk, donate, and tell others about Obliteride.